Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008).
This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chem…
Non Small Cell Lung Cancer (Squamous or Non Squamous)Stage 4 NSCLC
Estimated
~$10 – $8,750
Eikon TherapeuticsNCT07365319
Phase 2
Phase II Trial of Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standar…
Stage 4 NSCLCRadiotherapy
Estimated
~$10 – $6,250
University of RochesterNCT06262321